1421-1430 of 4249 results
Doubling of FIRB application fees
On 22 July 2022, the Government released changes to the FIRB application fee regime, in the form of the Foreign Acquisitions and Takeovers Fees Imposition Amendment (Fee Doubling) Regulations 2022 (Cth). The Amending Regulations provide for a doubling of FIRB application fees from 29 July 2022, we outline and comment on the fee increases. ...
Allens advises Octopus Australia on launch of renewable energy funds
OASIS and OREO will co-invest into an Australian renewable energy portfolio, across wind, solar and storage projects. The investment platform will finance the entire renewable energy life cycle fro ...
In Touch: Energy industry granted interim authorisation and other developments
The latest in competition and consumer law. ...
Allens tops mid-year M&A league tables
Allens ranked first for deal value in the announced Australasian M&A league tables in both the Mergermarket and Bloomberg rankings, and second in the Refinitiv rankings. The firm also topped ...
Employment and Safety: Key employment changes from 1 July 2022 and other developments
The latest issues, decisions and proposed changes impacting business and workplace risk ...
Allens advises Igneo Infrastructure Partners on the acquisition of Elliott Green Power Australia
Under the deal, Atmos Renewables has acquired EGP's portfolio of the Childers, Susan River and Nevertire solar farms with a combined capacity of 302 MW, generating approximately 500GWh of energy ...
Allens advises Liontown on world-class Kathleen Valley Lithium Project
With the execution of the third offtake agreement and funding facility with Ford, the Liontown Board made the Final Investment Decision to proceed to develop the project. 'This is a significant ...
The mRNA rush
There is great potential for mRNA technology to revolutionise future vaccines, and treatment of various conditions such as rare genetic disorders, other infectious diseases and even cancer. The enthusiasm for the technology – or the 'mRNA rush' – is reflected by a spike in patent filings over the past five years, and the growing patent portfolios of key mRNA pioneers and market players. ...
Failure to pay patent renewal fee? Advanta can take advantage of extension of time provision
Advanta Seeds Pty Ltd (Advanta), a broadacre seed company that owns thousands of patents relating to agricultural chemicals, seeds and seed technologies, applied for review of a decision by the Commissioner of Patents refusing its application under s 223 Patents Act 1990 (Cth) (Patents Act) for an e ...